-+ 0.00%
-+ 0.00%
-+ 0.00%

Nouscom raises EUR 120 million in Series D with CDP Venture Capital participation

PUBT·10/19/2026 10:14:04
Listen to the news
Nouscom raises EUR 120 million in Series D with CDP Venture Capital participation
  • Nouscom, a clinical-stage cancer immunotherapy developer, raised €120 million ($135 million) in an oversubscribed Series D financing.
  • M Ventures and Revelation Partners co-led the round, with participation from all existing investors, including CDP Venture Capital Large Ventures.
  • New investors included Angelini Industries, the European Investment Bank and Neva SGR.
  • Proceeds will fund a global, registration-enabling trial of NOUS-209, its investigational off-the-shelf cancer immunotherapy, for cancer interception in Lynch syndrome carriers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cdp Venture Capital Sgr SpA published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.